Contact Molecules for Homologous Proteins | ||||
![]() [Full Bars] |
![]() [SiteTable] |
|
![]() [Back to Search Page] |
![]() [Back to HOMCOS] |
![]() [help] |
seq_id(%): [0] [30] [40] [50] [60] [70] [80] [90] [95] [100] | ![]() [show] [download] [help] |
PID | QueryLength | Homolgous Sequence in PDB | UniProt Query | TITLE |
1681869 | 1025 | 297 | Q9BYX4(IFIH1_HUMAN) | RecName: Full=Interferon-induced helicase C domain-containing protein 1 ; EC=3.6.4.13 ;AltName: Full=Clinically amyopathic dermatomyositis autoantigen 140 kDa; Short=CADM-140 autoantigen;AltName: Full=Helicase with 2 CARD domains; Short=Helicard;AltName: Full=Interferon-induced with helicase C domain protein 1;AltName: Full=Melanoma differentiation-associated protein 5; Short=MDA-5;AltName: Full=Murabutide down-regulated protein;AltName: Full=RIG-I-like receptor 2; Short=RLR-2;AltName: Full=RNA helicase-DEAD box protein 116; |
QUERYSEQ |
MSNGYSTDENFRYLISCFRARVKMYIQVEPVLDYLTFLPAEVKEQIQRTVATSGNMQAVELLLSTLEKGVWHLGWTREFVEALRRTGSPLAARYMNPELTDLPSPSFENAHDEYLQLLNLLQPTLVDKLLVRDVLDKCMEEELLTIEDRN RIAAAENNGNESGVRELLKRIVQKENWFSAFLNVLRQTGNNELVQELTGSDCSESNAEIENLSQVDGPQVEEQLLSTTVQPNLEKEVWGMENNSSESSFADSSVVSESDTSLAEGSVSCLDESLGHNSNMGSDSGTMGSDSDEENVAARA SPEPELQLRPYQMEVAQPALEGKNIIICLPTGSGKTRVAVYIAKDHLDKKKKASEPGKVIVLVNKVLLVEQLFRKEFQPFLKKWYRVIGLSGDTQLKISFPEVVKSCDIIISTAQILENSLLNLENGEDAGVQLSDFSLIIIDECHHTNK EAVYNNIMRHYLMQKLKNNRLKKENKPVIPLPQILGLTASPGVGGATKQAKAEEHILKLCANLDAFTIKTVKENLDQLKNQIQEPCKKFAIADATREDPFKEKLLEIMTRIQTYCQMSPMSDFGTQPYEQWAIQMEKKAAKEGNRKERVC AEHLRKYNEALQINDTIRMIDAYTHLETFYNEEKDKKFAVIEDDSDEGGDDEYCDGDEDEDDLKKPLKLDETDRFLMTLFFENNKMLKRLAENPEYENEKLTKLRNTIMEQYTRTEESARGIIFTKTRQSAYALSQWITENEKFAEVGVK AHHLIGAGHSSEFKPMTQNEQKEVISKFRTGKINLLIATTVAEEGLDIKECNIVIRYGLVTNEIAMVQARGRARADESTYVLVAHSGSGVIEHETVNDFREKMMYKAIHCVQNMKPEEYAHKILELQMQSIMEKKMKTKRNIAKHYKNNP SLITFLCKNCSVLACSGEDIHVIEKMHHVNMTPEFKELYIVRENKALQKKCADYQINGEIICKCGQAWGTMMVHKGLDLPCLKIRNFVVVFKNNSTKKQYKKWVELPITFPNLDYSECCLFSDED |
1025 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
region | name | description |
![]() |
1-1025 | CHAIN | /note="Interferon-induced helicase C domain-containing protein 1" /id="PRO_0000102012" |
![]() ![]() ![]() |
7-97 | DOMAIN | /note="CARD 1" |
![]() ![]() ![]() |
110-190 | DOMAIN | /note="CARD 2" |
![]() ![]() ![]() |
316-509 | DOMAIN | /note="Helicase ATP-binding" |
![]() ![]() ![]() |
700-882 | DOMAIN | /note="Helicase C-terminal" |
![]() ![]() ![]() |
893-1020 | DOMAIN | /note="RLR CTR" |
![]() ![]() ![]() |
271-307 | REGION | /note="Disordered" |
![]() ![]() ![]() |
640-662 | REGION | /note="Disordered" |
![]() ![]() ![]() |
271-291 | COMPBIAS | /note="Polar residues" |
![]() ![]() ![]() |
644-659 | COMPBIAS | /note="Acidic residues" |
![]() ![]() ![]() |
907-907 | BINDING | /ligand="Zn(2+)" /ligand_id="ChEBI:CHEBI:29105" |
![]() ![]() ![]() |
910-910 | BINDING | /ligand="Zn(2+)" /ligand_id="ChEBI:CHEBI:29105" |
![]() ![]() ![]() |
962-962 | BINDING | /ligand="Zn(2+)" /ligand_id="ChEBI:CHEBI:29105" |
![]() ![]() ![]() |
964-964 | BINDING | /ligand="Zn(2+)" /ligand_id="ChEBI:CHEBI:29105" |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
1-1025 | DISORDER | predicted by DISOPRED |
![]() |
|||||||
1025 | |||||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
pdb_id | a1 | identity[%]2 | description | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 99.7 | IFIH1_HUMAN Interferon-induced helicase C domain-containing protein 1 | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | 100.0 | IFIH1_HUMAN Interferon-induced helicase C domain-containing protein 1 | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 100.0 | IFIH1_HUMAN Interferon-induced helicase C domain-containing protein 1 | |||
1.a1:asym_id for the homologue. 2.identity[%]2:sequence identity between the query and the homologue. |
![]() |
|||||||
1025 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | UBB_HUMAN Ubiquitin[73 aa] | E | 100.0 /100.0 |
6 /6 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | UBB_HUMAN Ubiquitin[72 aa] | E | 100.0 /100.0 |
22 /22 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | UBB_HUMAN Ubiquitin[74 aa] | E | 100.0 /100.0 |
10 /10 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
L | UBB_HUMAN Ubiquitin[73 aa] | E | 100.0 /100.0 |
13 /13 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M | MAVS_HUMAN Mitochondrial antiviral-signaling protein[97 aa] | E | 100.0 /100.0 |
9 /9 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M | MAVS_HUMAN Mitochondrial antiviral-signaling protein[97 aa] | H | 100.0 /100.0 |
6 /6 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | TRI65_HUMAN Tripartite motif-containing protein 65[180 aa] | C | 100.0 /99.7 |
11 /11 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | V_SV5 Non-structural protein V[52 aa] | A | 100.0 /87.8 |
26 /26 |
A7LCX1_PIG A7LCX1_PIG Melanoma differentiation associated protein-5 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | RN135_HUMAN E3 ubiquitin-protein ligase RNF135[171 aa] | A | 20.0 /41.0 |
10 /10 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | RN135_HUMAN E3 ubiquitin-protein ligase RNF135[169 aa] | A | 0.0 /41.4 |
1 /1 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | PRP8_YEAST Pre-mRNA-splicing factor 8[266 aa] | A | 28.6 /37.9 |
7 /60 |
BRR2_YEAST Pre-mRNA-splicing helicase BRR2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | PRP8_YEAST Pre-mRNA-splicing factor 8[2200 aa] | B | 33.3 /37.9 |
6 /52 |
BRR2_YEAST Pre-mRNA-splicing helicase BRR2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | RSE1_YEAST Pre-mRNA-splicing factor RSE1[1180 aa] | B | 50.0 /37.9 |
2 /18 |
BRR2_YEAST Pre-mRNA-splicing helicase BRR2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | M9MRT5_DROME Loquacious, isoform D[16 aa] | A | 0.0 /36.3 |
1 /26 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | M9MRT5_DROME Loquacious, isoform D[16 aa] | A | 0.0 /36.3 |
1 /23 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q9VLW8_DROME LD06392p[126 aa] | D | 0.0 /36.3 |
1 /12 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
EB | IF4G1_HUMAN Eukaryotic translation initiation factor 4 gamma 1.. | DB | 12.5 /33.8 |
8 /22 |
IF4A1_HUMAN Eukaryotic initiation factor 4A-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
U | EIF3L_HUMAN Eukaryotic translation initiation factor 3 subunit.. | DB | 33.3 /33.8 |
3 /5 |
IF4A1_HUMAN Eukaryotic initiation factor 4A-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | Q63UP7_BURPS Burkholderia Lethal Factor 1 (BLF1)[210 aa] | B | 25.0 /33.8 |
12 /31 |
IF4A1_HUMAN Eukaryotic initiation factor 4A-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | IF4G1_HUMAN Eukaryotic translation initiation factor 4 gamma 1.. | A | 12.5 /33.8 |
8 /22 |
IF4A1_HUMAN Eukaryotic initiation factor 4A-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | OSKA_DROME Maternal effect protein oskar[92 aa] | A | 17.4 /32.7 |
23 /23 |
VASA1_DROME ATP-dependent RNA helicase vasa, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | PDCD4_HUMAN Programmed cell death protein 4[284 aa] | C | 50.0 /32.7 |
12 /25 |
IF4A1_HUMAN Eukaryotic initiation factor 4A-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | UVRB_BACSU 40-mer from UvrABC system protein B[38 aa] | B | 0.0 /32.2 |
1 /8 |
UVRB_BACSU UvrABC system protein B |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | IF4F1_YEAST EUKARYOTIC INITIATION FACTOR 4F SUBUNIT P150[239 a.. | A | 30.0 /30.9 |
20 /30 |
IF4A_YEAST ATP-DEPENDENT RNA HELICASE EIF4A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MGN_HUMAN Protein mago nashi homolog[144 aa] | E | 33.3 /29.3 |
6 /33 |
DDX48_HUMAN Probable ATP-dependent RNA helicase DDX48 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | MGN2_HUMAN Protein mago nashi homolog 2[144 aa] | D | 33.3 /29.3 |
6 /33 |
IF4A3_HUMAN Eukaryotic initiation factor 4A-III |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | CASC3_HUMAN Protein CASC3[56 aa] | E | 30.8 /29.3 |
13 /41 |
DDX48_HUMAN Probable ATP-dependent RNA helicase DDX48 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | RBM8A_HUMAN RNA-binding protein 8A[91 aa] | I | 100.0 /29.3 |
1 /2 |
DDX48_HUMAN Probable ATP-dependent RNA helicase DDX48 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | RBM8A_HUMAN RNA-BINDING PROTEIN 8A[89 aa] | A | 100.0 /29.3 |
1 /3 |
DDX48_HUMAN ATP-DEPENDENT RNA HELICASE DDX48 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | REN3B_HUMAN REGULATOR OF NONSENSE TRANSCRIPTS 3B[15 aa] | A | 0.0 /29.3 |
6 /11 |
IF4A3_HUMAN EUKARYOTIC INITIATION FACTOR 4A-III |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | REN3B_HUMAN REGULATOR OF NONSENSE TRANSCRIPTS 3B[17 aa] | K | 0.0 /29.3 |
5 /9 |
IF4A3_HUMAN EUKARYOTIC INITIATION FACTOR 4A-III |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | CWC22_HUMAN PRE-MRNA-SPLICING FACTOR CWC22 HOMOLOG[277 aa] | A | 20.8 /29.8 |
24 /39 |
IF4A3_HUMAN EUKARYOTIC INITIATION FACTOR 4A-III |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | CWC22_HUMAN Pre-mRNA-splicing factor CWC22 homolog[274 aa] | F | 15.8 /30.9 |
19 /23 |
IF4A3_HUMAN Eukaryotic initiation factor 4A-III |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | CWC22_HUMAN Pre-mRNA-splicing factor CWC22 homolog[272 aa] | F | 33.3 /30.9 |
9 /12 |
IF4A3_HUMAN Eukaryotic initiation factor 4A-III |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S | CWC22_HUMAN Pre-mRNA-splicing factor CWC22 homolog[253 aa] | UA | 0.0 /29.3 |
2 /2 |
IF4A3_HUMAN Eukaryotic initiation factor 4A-III |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
V | CWC22_HUMAN Pre-mRNA-splicing factor CWC22 homolog[452 aa] | UA | 0.0 /29.3 |
4 /11 |
IF4A3_HUMAN Eukaryotic initiation factor 4A-III |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
V | CWC22_HUMAN Pre-mRNA-splicing factor CWC22 homolog[452 aa] | C | 0.0 /29.3 |
1 /1 |
IF4A3_HUMAN Eukaryotic initiation factor 4A-III |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N | CWC22_HUMAN Pre-mRNA-splicing factor CWC22 homolog[459 aa] | D | 0.0 /29.3 |
4 /11 |
IF4A3_HUMAN Eukaryotic initiation factor 4A-III |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
XA | CASC3_HUMAN Protein CASC3[25 aa] | UA | 30.8 /29.3 |
13 /18 |
IF4A3_HUMAN Eukaryotic initiation factor 4A-III |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | D8AM26_ECOLX REGULATOR OF RIBONUCLEASE ACTIVITY A[158 aa] | D | 21.4 /29.0 |
14 /17 |
SRMB_ECOLI ATP-DEPENDENT RNA HELICASE SRMB |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
1025 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | RNA (44-MER) | C | 92.9 /99.7 |
14 /14 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (44-MER) | C | 100.0 /99.7 |
21 /21 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(*AP*UP*CP*CP*GP*CP*GP*GP*CP*CP*CP*U)-3').. | A | 92.9 /99.7 |
14 /14 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | RNA (5'-R(P*AP*GP*GP*GP*CP*CP*GP*CP*GP*GP*AP*U)-3'.. | A | 100.0 /99.7 |
29 /29 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(P*UP*CP*CP*AP*UP*GP*CP*GP*CP*AP*UP*GP*AP.. | A | 86.7 /87.0 |
15 /15 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(P*UP*CP*CP*AP*UP*GP*CP*GP*CP*AP*UP*GP*AP.. | A | 81.8 /87.3 |
11 /11 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(P*UP*CP*CP*AP*UP*GP*CP*GP*CP*AP*UP*GP*AP.. | A | 86.7 /87.0 |
15 /15 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(P*UP*CP*CP*AP*UP*GP*CP*GP*CP*AP*UP*GP*AP.. | A | 83.3 /87.2 |
12 /12 |
IFIH1_MOUSE Isoform 2 of Interferon-induced helicase C domain-.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(P*UP*CP*CP*AP*UP*GP*CP*GP*CP*AP*UP*GP*AP.. | A | 50.0 /87.2 |
2 /2 |
IFIH1_MOUSE Isoform 2 of Interferon-induced helicase C domain-.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(P*UP*CP*CP*AP*UP*GP*CP*GP*CP*AP*UP*GP*AP.. | A | 100.0 /87.2 |
2 /2 |
IFIH1_MOUSE Isoform 2 of Interferon-induced helicase C domain-.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(P*CP*GP*UP*CP*AP*UP*GP*CP*GP*CP*AP*UP*GP.. | A | 100.0 /87.0 |
26 /26 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(P*CP*GP*UP*CP*AP*UP*GP*CP*GP*CP*AP*UP*GP.. | A | 100.0 /87.3 |
25 /25 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(P*CP*GP*UP*CP*AP*UP*GP*CP*GP*CP*AP*UP*GP.. | A | 100.0 /87.0 |
27 /27 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(P*CP*GP*UP*CP*AP*UP*GP*CP*GP*CP*AP*UP*GP.. | A | 0.0 /87.2 |
1 /1 |
IFIH1_MOUSE Isoform 2 of Interferon-induced helicase C domain-.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(P*CP*AP*AP*GP*CP*CP*GP*AP*GP*GP*AP*GP*AP.. | A | 85.7 /87.4 |
21 /21 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(P*CP*AP*AP*GP*CP*CP*GP*AP*GP*GP*AP*GP*AP.. | A | 85.7 /87.4 |
21 /21 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(P*CP*AP*AP*GP*CP*CP*GP*AP*GP*GP*AP*GP*AP.. | A | 90.0 /87.2 |
20 /20 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(P*CP*UP*CP*UP*CP*CP*UP*CP*GP*GP*CP*UP*UP.. | A | 100.0 /87.4 |
29 /29 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(P*CP*UP*CP*UP*CP*CP*UP*CP*GP*GP*CP*UP*UP.. | A | 100.0 /87.4 |
30 /30 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(P*CP*AP*AP*GP*CP*CP*GP*AP*GP*GP*AP*GP*AP.. | A | 83.3 /87.1 |
18 /18 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(P*AP*UP*CP*UP*CP*CP*UP*CP*GP*GP*CP*UP*UP.. | A | 100.0 /87.1 |
22 /22 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(P*GP*UP*CP*AP*AP*GP*CP*CP*GP*AP*GP*GP*AP.. | A | 93.3 /87.2 |
15 /15 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(P*GP*UP*CP*AP*AP*GP*CP*CP*GP*AP*GP*GP*AP.. | A | 84.2 /87.0 |
19 /19 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(P*UP*CP*UP*CP*CP*UP*CP*GP*GP*CP*UP*UP*GP.. | A | 100.0 /87.2 |
26 /26 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(P*GP*GP*AP*CP*GP*UP*CP*AP*UP*GP*CP*GP*CP.. | A | 75.0 /73.6 |
20 /20 |
D9N195_CHICK Melanoma differentiation associated protein-5 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(P*GP*GP*AP*CP*GP*UP*CP*AP*UP*GP*CP*GP*CP.. | B | 93.3 /73.9 |
30 /30 |
D9N195_CHICK Melanoma differentiation associated protein-5 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | RNA (5'-R(P*GP*GP*GP*AP*CP*GP*UP*CP*AP*UP*GP*CP*GP.. | A | 96.8 /73.6 |
31 /31 |
D9N195_CHICK Melanoma differentiation associated protein-5 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | RNA (5'-R(P*GP*GP*GP*AP*CP*GP*UP*CP*AP*UP*GP*CP*GP.. | B | 73.7 /73.9 |
19 /19 |
D9N195_CHICK Melanoma differentiation associated protein-5 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(P*GP*GP*UP*AP*CP*GP*UP*AP*CP*C)-3') | A | 70.3 /47.8 |
37 /37 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(P*GP*GP*UP*AP*CP*GP*UP*AP*CP*C)-3') | A | 75.0 /72.8 |
20 /20 |
D9N195_CHICK Melanoma differentiation associated protein-5 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(P*GP*GP*UP*AP*CP*GP*UP*AP*CP*C)-3') | A | 93.3 /72.8 |
30 /30 |
D9N195_CHICK Melanoma differentiation associated protein-5 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(P*AP*GP*GP*UP*AP*CP*GP*UP*AP*CP*C)-3') | A | 96.6 /72.8 |
29 /29 |
D9N195_CHICK Melanoma differentiation associated protein-5 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(P*GP*GP*UP*AP*GP*CP*GP*CP*UP*AP*CP*C)-3'.. | A | 53.8 /48.8 |
26 /26 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(P*GP*GP*UP*AP*GP*CP*GP*CP*UP*AP*CP*C)-3'.. | A | 70.6 /48.8 |
34 /34 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(P*GP*GP*UP*AP*CP*GP*UP*AP*CP*CP*C)-3') | A | 46.2 /47.8 |
26 /26 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(*GPPP*GP*AP*GP*CP*GP*UP*GP*CP*CP*GP*GP*G.. | A | 52.2 /47.5 |
67 /67 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(*GPPP*GP*UP*AP*CP*GP*UP*AP*CP*CP*C)-3') .. | A | 46.2 /47.0 |
26 /26 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(*GPPP*GP*UP*AP*CP*GP*UP*AP*CP*C)-3') | A | 69.4 /47.0 |
36 /36 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(P*AP*AP*UP*AP*UP*AP*AP*UP*AP*GP*UP*GP*AP.. | A | 63.9 /41.7 |
36 /37 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(*CP*GP*AP*CP*GP*CP*UP*AP*GP*CP*GP*U)-3').. | A | 50.0 /41.8 |
18 /18 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(*CP*GP*AP*CP*GP*CP*UP*AP*GP*CP*GP*U)-3').. | A | 63.0 /41.8 |
27 /27 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 5'-R(*GP*CP*AP*UP*GP*CP*GP*AP*CP*CP*UP*CP*UP*GP *U.. | A | 14.3 /41.5 |
7 /7 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 5'-R(*UP*CP*AP*AP*AP*CP*AP*GP*AP*GP*GP*UP*CP*GP *C.. | A | 62.5 /41.5 |
24 /24 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | dsRNA strand1 | A | 46.2 /41.4 |
13 /14 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | dsRNA strand 2 | A | 70.8 /41.4 |
24 /24 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | RNA (5'-R(*GP*GP*UP*AP*GP*AP*CP*GP*CP*UP*UP*CP*GP*.. | B | 54.3 /41.0 |
46 /46 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | 5'-R(*GP*CP*AP*UP*GP*CP*GP*AP*CP*CP*UP*CP*UP*GP *U.. | B | 14.3 /41.0 |
7 /7 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 5'-R(*UP*CP*AP*AP*AP*CP*AP*GP*AP*GP*GP*UP*CP*GP *C.. | B | 64.0 /41.0 |
25 /25 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | RNA (5'-R(P*GP*AP*CP*UP*GP*AP*CP*UP*GP*AP*CP*UP*GP.. | C | 90.9 /99.7 |
11 /11 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | dsRNA strand 1 | A | 37.5 /41.0 |
16 /17 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(P*UP*CP*AP*GP*UP*CP*AP*GP*UP*CP*AP*GP*UP.. | C | 100.0 /99.7 |
21 /21 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | dsRNA strand 2 | A | 66.7 /41.0 |
27 /27 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | OHSLR30 | A | 50.0 /40.8 |
54 /55 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | p3SLR30 | A | 50.0 /40.7 |
56 /57 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | RNA (5'-R(*CP*GP*AP*CP*GP*CP*UP*AP*GP*CP*GP*UP*CP*.. | C | 47.4 /40.7 |
19 /19 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(*CP*GP*AP*CP*GP*CP*UP*AP*GP*CP*GP*UP*CP*.. | C | 67.9 /40.7 |
28 /29 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | 5'-R-PPP(GP*GP*CP*GP*CP*GP*GP*CP*UP*UP*CP*GP*GP*CP.. | A | 40.0 /40.6 |
30 /31 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | p3dsRNAa | A | 39.1 /40.4 |
23 /24 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | p3dsRNAb | A | 66.7 /40.4 |
21 /21 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | 5'-R(*GP*CP*GP*CP*GP*CP*GP*CP*GP*CP)-3' | A | 33.3 /40.5 |
15 /16 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 5'-R(*GP*CP*GP*CP*GP*CP*GP*CP*GP*CP)-3' | A | 50.0 /40.5 |
16 /16 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(P*GP*AP*AP*UP*AP*UP*AP*AP*UP*AP*GP*UP*GP.. | A | 60.5 /40.7 |
38 /40 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | p2dsRNA | A | 36.0 /40.4 |
25 /26 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | p2dsRNA | A | 65.5 /40.4 |
29 /29 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | OHdsRNA | A | 38.5 /40.1 |
26 /27 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | OHdsRNA | A | 67.9 /40.1 |
28 /28 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | OHSLR30 | A | 54.3 /40.1 |
46 /48 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | 59-nt precursor of miR-15a | A | 0.0 /40.1 |
1 /15 |
DICER_MOUSE Endoribonuclease Dicer |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | p3SLR30 | A | 60.0 /40.0 |
40 /41 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | p3SLR30 | A | 62.5 /40.0 |
32 /33 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (73-mer) | A | 40.0 /39.8 |
5 /31 |
DICER_HUMAN Endoribonuclease Dicer |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (73-mer) | A | 0.0 /39.8 |
2 /27 |
DICER_HUMAN Endoribonuclease Dicer |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(*GP*GP*AP*GP*GP*UP*AP*GP*UP*AP*GP*GP*UP*.. | A | 100.0 /38.4 |
1 /1 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | U4 snRNA | I | 33.3 /37.9 |
15 /60 |
BRR2_YEAST Pre-mRNA-splicing helicase BRR2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | Saccharomyces cerevisiae strain UOA_M2 chromosome .. | I | 33.3 /37.9 |
15 /59 |
BRR2_YEAST Pre-mRNA-splicing helicase BRR2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | U4 snRNA | I | 36.4 /37.9 |
11 /51 |
BRR2_YEAST Pre-mRNA-splicing helicase BRR2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q | U4 snRNA | AA | 36.4 /37.9 |
11 /49 |
BRR2_YEAST Pre-mRNA-splicing helicase BRR2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Z | U4 snRNA | AA | 50.0 /37.9 |
8 /31 |
BRR2_YEAST Pre-mRNA-splicing helicase BRR2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(P*UP*GP*AP*GP*G)-3') | A | 0.0 /36.5 |
3 /5 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | RNA (5'-R(P*CP*CP*UP*CP*UP*CP*U)-3') | A | 75.0 /36.5 |
8 /8 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (30-MER) | A | 0.0 /36.3 |
5 /17 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | RNA (32-MER) | A | 58.3 /36.3 |
12 /29 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (35-MER) | A | 0.0 /36.3 |
6 /20 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | RNA (35-MER) | A | 61.5 /36.3 |
13 /29 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | dsRNA | D | 58.3 /36.3 |
12 /37 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | dsRNA | D | 0.0 /36.3 |
5 /22 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | dsRNA | C | 0.0 /36.3 |
5 /38 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | dsRNA | C | 60.0 /36.3 |
10 /61 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | siRNA | A | 0.0 /36.3 |
6 /19 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | siRNA | A | 66.7 /36.3 |
9 /32 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | RNA (52-MER) | A | 0.0 /36.3 |
7 /15 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | RNA (52-MER) | A | 53.8 /36.3 |
13 /24 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | RNA (5'-R(P*GP*AP*GP*AP*CP*UP*UP*GP*G)-3') | A | 0.0 /36.3 |
6 /13 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | RNA (5'-R(P*CP*CP*AP*AP*GP*UP*CP*UP*CP*UP*U)-3') | A | 70.0 /36.3 |
10 /23 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | pri-miRNA 166f | A | 28.6 /35.4 |
35 /74 |
DCL1_ARATH Endoribonuclease Dicer homolog 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | pre-miRNA 166f | A | 31.2 /35.4 |
32 /63 |
DCL1_ARATH Endoribonuclease Dicer homolog 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 5'-R(*GP*CP*GP*CP*GP*CP*GP*C)-3' | A | 40.0 /34.8 |
15 /15 |
DHX58_HUMAN ATP-dependent RNA helicase DHX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 5'-R(*GP*CP*GP*CP*GP*CP*GP*C)-3' | A | 66.7 /34.8 |
6 /6 |
DHX58_HUMAN ATP-dependent RNA helicase DHX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(*AP*GP*AP*GP*AP*GP*AP*GP*AP*G)-3') | A | 44.4 /34.2 |
9 /26 |
IF4A1_HUMAN Eukaryotic initiation factor 4A-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(*AP*GP*AP*GP*AP*GP*AP*GP*AP*G)-3') | A | 44.4 /34.2 |
9 /26 |
IF4A1_MOUSE Eukaryotic initiation factor 4A-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | 5'-R(*GP*GP*GP*AP*GP*AP*AP*CP*AP*AP*CP*GP*CP*GP)-3.. | A | 50.0 /34.0 |
8 /9 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 5'-R(*CP*GP*CP*GP*UP*UP*GP*UP*UP*CP*UP*CP*CP*CP)-3.. | B | 50.0 /34.0 |
8 /9 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | 5'-R(*UP*GP*AP*CP*AP*UP)-3' | A | 33.3 /33.3 |
9 /24 |
O01378_BOMMO BMVLG PROTEIN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 5'-R(*UP*UP*UP*UP*UP*UP*UP*UP*UP*U)-3' | E | 33.3 /32.7 |
9 /21 |
VASA_DROME ATP-dependent RNA helicase vasa |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 5'-R(*UP*UP*UP*UP*UP*UP*UP*UP*UP*U)-3' | H | 33.3 /32.7 |
9 /21 |
VASA_DROME ATP-dependent RNA helicase vasa |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | DNA (5'-D(P*CP*CP*AP*TP*CP*GP*CP*GP*CP*TP*AP*CP*C).. | A | 22.2 /32.5 |
9 /17 |
UVRB_BACCA UvrABC system protein B |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | DNA (5'-D(P*AP*GP*CP*GP*CP*GP*AP*TP*GP*GP*AP*GP*A).. | A | 25.0 /32.5 |
4 /8 |
UVRB_BACCA UvrABC system protein B |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 5'-D(P*TP*TP*T)-3' | B | 0.0 /32.2 |
1 /13 |
UVRB_BACSU UvrABC system protein B |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 5'-D(P*TP*TP*TP*TP*T)-3' | B | 33.3 /32.2 |
3 /19 |
UVRB_BACSU UvrABC system protein B |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | DNA: 5 -TACTGTTT-3 | A | 20.0 /32.2 |
5 /22 |
UVRB_BACSU UvrABC system protein B |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(*(GTP)P*GP*CP*GP*CP*GP*CP*GP*CP*GP*CP*GP.. | A | 33.3 /31.6 |
15 /15 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | RNA (5'-R(*(GTP)P*GP*CP*GP*CP*GP*CP*GP*CP*GP*CP*GP.. | A | 0.0 /31.6 |
3 /3 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(*(ATP)P*UP*AP*UP*AP*UP*AP*UP*AP*UP*AP*U).. | A | 40.0 /31.6 |
15 /15 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() |
![]() |
D | RNA (5'-R(*(ATP)P*UP*AP*UP*AP*UP*AP*UP*AP*UP*AP*U).. | A | 25.0 /31.6 |
4 /4 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 5'-R(*(GDP)P*AP*CP*GP*CP*UP*AP*GP*CP*GP*UP*C)-3' | A | 46.2 /31.6 |
13 /13 |
DDX58_HUMAN RIG-I |
![]() ![]() ![]() ![]() ![]() |
![]() |
D | 5'-R(*(GDP)P*AP*CP*GP*CP*UP*AP*GP*CP*GP*UP*C)-3' | A | 25.0 /31.6 |
4 /4 |
DDX58_HUMAN RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(*(GDP)P*AP*CP*GP*CP*UP*AP*GP*CP*GP*UP*C).. | A | 54.5 /31.6 |
11 /11 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() |
![]() |
D | RNA (5'-R(*(GDP)P*AP*CP*GP*CP*UP*AP*GP*CP*GP*UP*C).. | A | 33.3 /31.6 |
3 /3 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(*GP*GP*CP*GP*CP*GP*CP*GP*CP*GP*CP*GP*CP*.. | A | 45.5 /31.6 |
11 /11 |
DDX58_HUMAN ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | RNA (5'-R(*GP*GP*CP*GP*CP*GP*CP*GP*CP*GP*CP*GP*CP*.. | A | 25.0 /31.6 |
4 /4 |
DDX58_HUMAN ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(*GP*AP*CP*GP*CP*UP*AP*GP*CP*GP*UP*C)-3').. | A | 45.5 /31.6 |
11 /11 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() |
![]() |
D | RNA (5'-R(*GP*AP*CP*GP*CP*UP*AP*GP*CP*GP*UP*C)-3').. | A | 33.3 /31.6 |
3 /3 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | DNA (41-MER) | A | 23.5 /31.6 |
17 /17 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | DNA (5'-D(*GP*CP*TP*CP*TP*AP*GP*AP*TP*TP*TP*TP*CP*.. | A | 20.0 /31.6 |
10 /37 |
UVRB_BACCA UvrABC system protein B |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | DNA (5'-D(*GP*CP*CP*GP*TP*AP*TP*GP*CP*CP*AP*AP*TP*.. | A | 25.0 /31.6 |
4 /20 |
UVRB_BACCA UvrABC system protein B |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | DNA (5'-D(*TP*CP*TP*CP*CP*AP*TP*CP*GP*CP*GP*CP*TP*.. | A | 20.0 /31.6 |
10 /26 |
UVRB_BACCA UvrABC system protein B |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | DNA (5'-D(*GP*GP*TP*AP*GP*CP*GP*CP*GP*AP*TP*GP*GP*.. | A | 20.0 /31.6 |
5 /14 |
UVRB_BACCA UvrABC system protein B |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | DNA (5'-D(*GP*GP*TP*AP*GP*CP*GP*CP*GP*AP*TP*GP*GP*.. | B | 33.3 /31.6 |
6 /12 |
UVRB_BACCA UvrABC system protein B |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 25-MER | C | 30.8 /31.2 |
13 /48 |
afUHEL308 HELICASE |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 5'-R(*UP*UP*UP*UP*UP*U)-3' | E | 40.0 /29.3 |
10 /25 |
DDX48_HUMAN Probable ATP-dependent RNA helicase DDX48 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | RNA | A | 40.0 /29.3 |
10 /23 |
IF4A3_HUMAN Eukaryotic initiation factor 4A-III, N-terminally .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | 5'-R(*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*U).. | A | 40.0 /29.3 |
10 /23 |
DDX48_HUMAN ATP-DEPENDENT RNA HELICASE DDX48 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | RNA POLY-U-RIBONUCLEOTIDE | A | 40.0 /29.3 |
10 /27 |
IF4A3_HUMAN EUKARYOTIC INITIATION FACTOR 4A-III |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | RNA POLY-U-RIBONUCLEOTIDE | K | 40.0 /29.3 |
10 /23 |
IF4A3_HUMAN EUKARYOTIC INITIATION FACTOR 4A-III |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | pre-mRNA | UA | 40.0 /29.3 |
10 /27 |
IF4A3_HUMAN Eukaryotic initiation factor 4A-III |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | Pre-mRNA | FA | 40.0 /29.3 |
10 /27 |
IF4A3_HUMAN Eukaryotic initiation factor 4A-III |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S | PM5 5' Exon | E | 27.3 /29.3 |
11 /29 |
IF4A3_HUMAN Eukaryotic initiation factor 4A-III |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
1025 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ADP
|
B | 100.0 /32.2 |
1 /16 |
UVRB_BACSU UvrABC system protein B |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
ADP
|
A | 83.3 /37.1 |
6 /10 |
HELS_PYRFU Putative ski2-type helicase |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
ADP
|
C | 100.0 /29.3 |
1 /17 |
IF4A3_HUMAN Eukaryotic initiation factor 4A-III |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
ADP
|
A | 100.0 /33.3 |
1 /19 |
O01378_BOMMO BMVLG PROTEIN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ADP
|
A | 100.0 /87.2 |
13 /13 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
ADP
|
A | 87.5 /41.0 |
8 /10 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
ADP
|
A | 80.0 /40.7 |
10 /12 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
M7G
|
A | 28.6 /40.7 |
7 /7 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
GTP
|
A | 22.2 /41.7 |
9 /10 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
GTP
|
A | 40.0 /40.0 |
10 /10 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
PE5
|
A | 0.0 /37.9 |
1 /7 |
BRR2_YEAST PRE-MRNA-SPLICING HELICASE BRR2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
ACP
|
A | 72.7 /37.1 |
11 /15 |
HELS_PYRFU Putative ski2-type helicase |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
V6D
|
A | 50.0 /34.2 |
2 /9 |
IF4A1_MOUSE Eukaryotic initiation factor 4A-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
ATP
|
A | 100.0 /31.6 |
1 /13 |
UVRB_BACCA EXCINUCLEASE UVRABC COMPONENT UVRB |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
ATP
|
A | 100.0 /87.2 |
10 /10 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
JB |
ATP
|
D | 75.0 /29.3 |
4 /20 |
IF4A3_HUMAN Eukaryotic initiation factor 4A-III |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
TB |
ATP
|
E | 42.9 /29.3 |
7 /18 |
IF4A3_HUMAN Eukaryotic initiation factor 4A-III |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
ANP
|
E | 100.0 /32.7 |
3 /23 |
VASA_DROME ATP-dependent RNA helicase vasa |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
ANP
|
E | 75.0 /29.3 |
4 /20 |
DDX48_HUMAN Probable ATP-dependent RNA helicase DDX48 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
ANP
|
A | 66.7 /42.5 |
12 /12 |
DDX58_MOUSE RIG-I Helicase Domain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
ANP
|
A | 100.0 /33.3 |
2 /22 |
O01378_BOMMO BMVLG PROTEIN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
ANP
|
A | 66.7 /34.2 |
3 /20 |
IF4A1_HUMAN Eukaryotic initiation factor 4A-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
ANP
|
A | 100.0 /87.4 |
10 /10 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
ANP
|
A | 66.7 /34.2 |
3 /23 |
IF4A1_MOUSE Eukaryotic initiation factor 4A-I |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
1025 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
NA
|
A | 100.0 /100.0 |
5 /5 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
ZN
|
A | 0.0 /30.6 |
3 /3 |
IF4A_YEAST EUKARYOTIC INITIATION FACTOR 4A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
ZN
|
A | 100.0 /31.6 |
4 /4 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
ZN
|
A | 100.0 /34.8 |
5 /6 |
DHX58_HUMAN ATP-dependent RNA helicase DHX58 |
![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
ZN
|
A | 100.0 /100.0 |
5 /5 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ZN
|
A | 100.0 /40.5 |
4 /4 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
ZN
|
A | 100.0 /31.6 |
4 /4 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
ZN
|
A | 100.0 /31.6 |
4 /4 |
DDX58_HUMAN RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
ZN
|
A | 100.0 /31.6 |
4 /4 |
DDX58_HUMAN ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
ZN
|
A | 100.0 /40.6 |
4 /4 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ZN
|
A | 100.0 /40.4 |
4 /4 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
ZN
|
A | 100.0 /99.7 |
5 /5 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ZN
|
A | 100.0 /47.8 |
4 /4 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ZN
|
A | 100.0 /47.0 |
4 /4 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ZN
|
A | 100.0 /87.4 |
4 /4 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ZN
|
C | 100.0 /40.7 |
5 /5 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ZN
|
A | 100.0 /87.2 |
5 /5 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ZN
|
A | 100.0 /87.2 |
5 /5 |
IFIH1_MOUSE Isoform 2 of Interferon-induced helicase C domain-.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
ZN
|
C | 100.0 /99.7 |
4 /4 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
ZN
|
A | 100.0 /41.0 |
4 /4 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ZN
|
A | 100.0 /40.4 |
4 /4 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
MG
|
A | 100.0 /29.3 |
1 /4 |
DDX48_HUMAN ATP-DEPENDENT RNA HELICASE DDX48 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
MG
|
A | 100.0 /42.3 |
2 /2 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
MG
|
A | 100.0 /41.5 |
4 /5 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
MG
|
A | 100.0 /40.6 |
3 /3 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
MG
|
A | 0.0 /41.8 |
2 /2 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
MG
|
A | 100.0 /41.8 |
1 /1 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
MG
|
A | 50.0 /40.7 |
2 /2 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
MG
|
A | 0.0 /41.1 |
1 /1 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
MG
|
A | 0.0 /41.7 |
4 /4 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
MG
|
A | 50.0 /41.7 |
2 /2 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
MG
|
A | 100.0 /41.7 |
1 /1 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
U |
MG
|
E | 0.0 /42.1 |
1 /1 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
X |
MG
|
G | 50.0 /41.5 |
2 /2 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
MG
|
A | 0.0 /47.0 |
1 /1 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
MG
|
A | 100.0 /87.2 |
1 /1 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
MG
|
C | 50.0 /40.7 |
2 /2 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R |
MG
|
B | 100.0 /31.6 |
1 /1 |
UVRB_BACCA UvrABC system protein B |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
MG
|
A | 100.0 /87.2 |
1 /1 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
MG
|
C | 100.0 /99.7 |
1 /1 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
MG
|
A | 0.0 /31.6 |
1 /1 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
MG
|
A | 100.0 /40.7 |
2 /2 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
HG
|
A | 100.0 /31.6 |
4 /4 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
HG
|
A | 100.0 /35.1 |
4 /4 |
DHX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DHX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
CL
|
A | 0.0 /36.8 |
2 /3 |
Q72GF3_THET2 Heat resistant RNA dependent ATPase |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
CL
|
B | 0.0 /36.8 |
1 /3 |
Q72GF3_THET2 Heat resistant RNA dependent ATPase |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
CL
|
B | 0.0 /44.0 |
2 /2 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
CL
|
A | 0.0 /31.6 |
1 /1 |
UVRB_BACCA UvrABC system protein B |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
1025 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. | E | 100.0 /100.0 |
17 /17 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. | E | 100.0 /100.0 |
15 /15 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. | C | 88.9 /99.7 |
9 /9 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. | C | 100.0 /99.7 |
9 /9 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | IFIH1_MOUSE Isoform 2 of Interferon-induced helicase C domain-.. | A | 63.6 /87.2 |
11 /11 |
IFIH1_MOUSE Isoform 2 of Interferon-induced helicase C domain-.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | IFIH1_MOUSE Isoform 2 of Interferon-induced helicase C domain-.. | A | 84.6 /87.2 |
13 /13 |
IFIH1_MOUSE Isoform 2 of Interferon-induced helicase C domain-.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | D9N195_CHICK Melanoma differentiation associated protein-5[647 .. | A | 57.1 /73.6 |
21 /21 |
D9N195_CHICK Melanoma differentiation associated protein-5 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[495 aa] | A | 46.9 /44.1 |
32 /40 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[648 aa] | A | 31.6 /40.7 |
19 /20 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[641 aa] | A | 19.2 /40.7 |
26 /26 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[647 aa] | A | 0.0 /40.7 |
1 /1 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[644 aa] | A | 0.0 /40.7 |
3 /3 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[647 aa] | C | 30.0 /40.9 |
10 /11 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[644 aa] | C | 0.0 /40.9 |
1 /3 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | DDX58_HUMAN Antiviral innate immune response receptor RIG-I[65.. | A | 0.0 /41.4 |
7 /7 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | DDX58_HUMAN Antiviral innate immune response receptor RIG-I[65.. | A | 0.0 /41.4 |
5 /6 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | A1ZAW0_DROME Dicer-2, isoform A[1478 aa] | A | 53.8 /36.3 |
13 /55 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | A1ZAW0_DROME Dicer-2, isoform A[1561 aa] | A | 0.0 /36.3 |
7 /28 |
A1ZAW0_DROME Dicer-2, isoform A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | DHX58_HUMAN ATP-dependent RNA helicase DHX58[142 aa] | A | 50.0 /34.8 |
2 /2 |
DHX58_HUMAN ATP-dependent RNA helicase DHX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | UVRB_BACSU UvrABC system protein B[579 aa] | A | 0.0 /32.2 |
4 /26 |
UVRB_BACSU UvrABC system protein B |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | IF4A_YEAST ATP-DEPENDENT RNA HELICASE EIF4A[366 aa] | A | 16.7 /30.9 |
12 /22 |
IF4A_YEAST ATP-DEPENDENT RNA HELICASE EIF4A |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
1025 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
ALF
|
A | 100.0 /47.8 |
8 /8 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
ALF
|
A | 100.0 /47.0 |
8 /8 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
ALF
|
A | 100.0 /87.2 |
6 /6 |
IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
ALF
|
C | 100.0 /99.7 |
6 /6 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
ALF
|
A | 100.0 /41.0 |
5 /5 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
EDO
|
A | 33.3 /42.5 |
6 /7 |
DDX58_MOUSE RIG-I Helicase Domain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
EDO
|
A | 80.0 /47.8 |
5 /5 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
EDO
|
A | 40.0 /47.8 |
5 /5 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
EDO
|
A | 66.7 /47.8 |
6 /6 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
MGF
|
A | 100.0 /47.8 |
1 /1 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
GOL
|
A | 80.0 /34.0 |
5 /8 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
GOL
|
A | 33.3 /34.0 |
3 /3 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
GOL
|
A | 0.0 /29.8 |
1 /1 |
IF4A3_HUMAN EUKARYOTIC INITIATION FACTOR 4A-III |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
GOL
|
A | 50.0 /29.8 |
4 /4 |
IF4A3_HUMAN EUKARYOTIC INITIATION FACTOR 4A-III |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 60.0 /29.8 |
5 /7 |
IF4A3_HUMAN EUKARYOTIC INITIATION FACTOR 4A-III |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
A | 25.0 /29.8 |
4 /4 |
IF4A3_HUMAN EUKARYOTIC INITIATION FACTOR 4A-III |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
GOL
|
A | 20.0 /29.8 |
5 /5 |
IF4A3_HUMAN EUKARYOTIC INITIATION FACTOR 4A-III |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
GOL
|
A | 0.0 /33.3 |
2 /3 |
O01378_BOMMO BMVLG PROTEIN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /41.8 |
5 /5 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
BEF
|
A | 100.0 /41.8 |
5 /5 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
AF3
|
C | 100.0 /29.3 |
2 /8 |
IF4A3_HUMAN Eukaryotic initiation factor 4A-III |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
AF3
|
A | 100.0 /41.5 |
9 /9 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
ETF
|
A | 77.8 /41.1 |
9 /9 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Y |
ETF
|
E | 20.0 /40.2 |
5 /5 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
CA |
ETF
|
G | 20.0 /40.3 |
5 /5 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
NA |
ETF
|
K | 66.7 /40.3 |
6 /6 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
BU3
|
A | 57.1 /41.1 |
7 /7 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
BU3
|
A | 80.0 /41.1 |
5 /5 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
U |
BU3
|
A | 20.0 /41.1 |
5 /5 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T |
BU3
|
C | 25.0 /40.4 |
4 /4 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
V |
BU3
|
C | 25.0 /40.4 |
4 /4 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
W |
BU3
|
C | 62.5 /40.4 |
8 /8 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
AA |
BU3
|
E | 44.4 /40.2 |
9 /9 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
EA |
BU3
|
G | 60.0 /40.3 |
5 /5 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
SO4
|
A | 33.3 /36.4 |
3 /3 |
H669_METJA PUTATIVE ATP-DEPENDENT RNA HELICASE MJ0669 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
SO4
|
A | 0.0 /35.1 |
3 /3 |
DHX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DHX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
SO4
|
C | 0.0 /35.8 |
3 /4 |
DHX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DHX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
SO4
|
A | 85.7 /40.5 |
7 /7 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
SO4
|
A | 50.0 /37.1 |
2 /3 |
HELS_PYRFU Putative ski2-type helicase |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
SO4
|
A | 100.0 /84.4 |
1 /1 |
IFIH1_MOUSE IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
SO4
|
A | 100.0 /84.4 |
4 /4 |
IFIH1_MOUSE IFIH1_MOUSE Interferon-induced helicase C domain-containing pr.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
SO4
|
B | 0.0 /36.8 |
1 /8 |
Q72GF3_THET2 Heat resistant RNA dependent ATPase |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
SO4
|
B | 0.0 /36.8 |
1 /5 |
Q72GF3_THET2 Heat resistant RNA dependent ATPase |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
SO4
|
A | 75.0 /44.1 |
4 /4 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
SO4
|
A | 33.3 /47.5 |
3 /3 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
SO4
|
A | 0.0 /47.5 |
3 /3 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
SO4
|
A | 100.0 /47.5 |
1 /1 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
SO4
|
A | 50.0 /47.5 |
4 /4 |
G0YYQ5_CHICK LGP2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
PO4
|
A | 85.7 /34.9 |
7 /7 |
Q8TZH8_PYRFU ATP-dependent RNA helicase, putative |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
PO4
|
A | 40.0 /30.9 |
5 /5 |
afuHEL308 HELICASE |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
PO4
|
A | 0.0 /30.9 |
1 /6 |
afuHEL308 HELICASE |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
PO4
|
A | 33.3 /30.9 |
3 /3 |
afuHEL308 HELICASE |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
PO4
|
A | 60.0 /30.9 |
5 /5 |
afuHEL308 HELICASE |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
PO4
|
A | 100.0 /33.3 |
1 /9 |
O01378_BOMMO BMVLG PROTEIN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
PO4
|
A | 100.0 /31.6 |
3 /7 |
UVRB_BACCA UvrABC system protein B |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. |